Athenex, Inc. to Report Second Quarter 2020 Earnings Results on August 6, 2020

NEXT STORY
Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting
PREV STORY
MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death

author_avatar
NASDAQ Market News

The EndoPredict® Test Significantly Outperforms the First-Generation Test in Predicting the Risk of Node-Negative and Node-Positive Breast Cancer Recurrence

SALT LAKE CITY, Dec. 09, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals Reports 3rd Quarter 2016 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

author_avatar
NASDAQ Market News